Determination of risk factors for progression in patients with viable tumor at post-chemotherapy lymph node dissection due to disseminated non-seminomatous germ-cell tumors.
Mesut AltanHakan Bahadır HaberalAhmet AşçıAhmet GüdeloğluAhmet Bülent DoğrulMustafa Sertaç YazıcıBülent AkdoğanHaluk ÖzenPublished in: International journal of clinical oncology (2020)
Retroperitoneal lymph node dissection with negative surgical margin is essential for patients with viable residual tumor after chemotherapy. Need for second-line chemotherapy shows risk of progression.